{
  "links": "https://www.ycombinator.com/companies/sixfold-bioscience",
  "name": "Sixfold Bioscience",
  "headline": "Delivering RNA therapies.",
  "batch": "W18",
  "description": "Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.",
  "activity_status": "Active",
  "website": "https://www.sixfold.bio",
  "founded_date": 2018.0,
  "team_size": 27.0,
  "location": "London, United Kingdom",
  "group_partner": null,
  "group_partner_yc": null,
  "company_linkedin": null,
  "company_twitter": null,
  "tags": "industry:gene-therapy; industry:nanomedicine; industry:drug-delivery",
  "founders": [],
  "status": true,
  "markdown": "raw_markdown='[](https://www.sixfold.bio/</>)[](https://www.sixfold.bio/</>)[Platform](https://www.sixfold.bio/</platform>)[Team](https://www.sixfold.bio/</team>)[Contact](https://www.sixfold.bio/</contact>)[News](https://www.sixfold.bio/</news>)\\n[](https://www.sixfold.bio/<https:/www.facebook.com/Sixfold.bio/>)[](https://www.sixfold.bio/<https:/twitter.com/sixfold_bio>)[](https://www.sixfold.bio/<https:/www.instagram.com/sixfold.bio/>)[](https://www.sixfold.bio/<https:/www.linkedin.com/company/sixfoldbioscience/>)\\n# RNA, evolved.\\n## We’re solving delivery to build the future of RNA therapies. Inspired by evolution, perfected with AI.\\n[Meet Mergo®](https://www.sixfold.bio/</platform>)\\n[Platform](https://www.sixfold.bio/</platform>)[Team](https://www.sixfold.bio/</team>)[Contact](https://www.sixfold.bio/</contact>)[News](https://www.sixfold.bio/</news>)\\n[![](https://cdn.prod.website-files.com/64abbc83480a5f17c05488ce/64ae189fc17c9ae16b9a4793_Sixfold%C2%AE_Symbol.png)](https://www.sixfold.bio/</>)\\n[](https://www.sixfold.bio/<https:/www.facebook.com/Sixfold.bio/>)[](https://www.sixfold.bio/<https:/twitter.com/sixfold_bio>)[](https://www.sixfold.bio/<https:/www.instagram.com/sixfold.bio/>)[](https://www.sixfold.bio/<https:/www.linkedin.com/company/sixfoldbioscience/>)\\n© 2023 Sixfold Bio. All rights reserved.\\n[Terms](https://www.sixfold.bio/</terms>)\\n[Cookies](https://www.sixfold.bio/</cookies>)\\n[Privacy](https://www.sixfold.bio/</privacy>)\\n' markdown_with_citations='[](https://www.sixfold.bio/</>)[](https://www.sixfold.bio/</>)Platform⟨1⟩Team⟨2⟩Contact⟨3⟩News⟨4⟩\\n[](https://www.sixfold.bio/<https:/www.facebook.com/Sixfold.bio/>)[](https://www.sixfold.bio/<https:/twitter.com/sixfold_bio>)[](https://www.sixfold.bio/<https:/www.instagram.com/sixfold.bio/>)[](https://www.sixfold.bio/<https:/www.linkedin.com/company/sixfoldbioscience/>)\\n# RNA, evolved.\\n## We’re solving delivery to build the future of RNA therapies. Inspired by evolution, perfected with AI.\\nMeet Mergo®⟨1⟩\\nPlatform⟨1⟩Team⟨2⟩Contact⟨3⟩News⟨4⟩\\n![⟨5⟩](https://www.sixfold.bio/</>)\\n[](https://www.sixfold.bio/<https:/www.facebook.com/Sixfold.bio/>)[](https://www.sixfold.bio/<https:/twitter.com/sixfold_bio>)[](https://www.sixfold.bio/<https:/www.instagram.com/sixfold.bio/>)[](https://www.sixfold.bio/<https:/www.linkedin.com/company/sixfoldbioscience/>)\\n© 2023 Sixfold Bio. All rights reserved.\\nTerms⟨6⟩\\nCookies⟨7⟩\\nPrivacy⟨8⟩\\n' references_markdown='\\n\\n## References\\n\\n⟨1⟩ https://www.sixfold.bio/</platform>: Platform\\n⟨2⟩ https://www.sixfold.bio/</team>: Team\\n⟨3⟩ https://www.sixfold.bio/</contact>: Contact\\n⟨4⟩ https://www.sixfold.bio/</news>: News\\n⟨5⟩ https://cdn.prod.website-files.com/64abbc83480a5f17c05488ce/64ae189fc17c9ae16b9a4793_Sixfold%C2%AE_Symbol.png: ![\\n⟨6⟩ https://www.sixfold.bio/</terms>: Terms\\n⟨7⟩ https://www.sixfold.bio/</cookies>: Cookies\\n⟨8⟩ https://www.sixfold.bio/</privacy>: Privacy\\n' fit_markdown='' fit_html=''",
  "generated_description": "Sixfold Bioscience is a forward-looking company that’s on a mission to revolutionize RNA therapies. Founded in 2018, and emerging from the Y Combinator Batch W18, this London-based firm is laser-focused on solving the intricate challenges of drug delivery, particularly for RNA therapeutics like small interfering RNAs (siRNAs) for gene silencing and messenger RNAs (mRNAs) for gene expression.\n\nAt its core, Sixfold aims to commercialize its patented drug delivery systems, effectively bridging the gap between groundbreaking RNA technology and real-world applications. Their signature platform is called Mergo®, a nod to the intersection of evolution and artificial intelligence in optimizing RNA delivery methods.\n\nWith a small but agile team of 27 employees, Sixfold has positioned itself as a key player in the fields of gene therapy, nanomedicine, and drug delivery. They actively engage in a variety of initiatives to advance their technological platform and expand their reach in the market.\n\nTheir ethos is clear: they’re dedicated to evolving RNA therapies by mastering the delivery process, a challenge that has stymied many in the biotech arena. \n\nIf you’re curious to learn more or keep up with their latest developments, their website is a good resource—[Sixfold Bioscience](https://www.sixfold.bio). \n\nIn short, Sixfold is blending innovation and practicality in the pursuit of bringing RNA therapies to the forefront of medicine, and they're just getting started."
}